Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 5 - Compounds containing elements of the 3rd group of the periodic system
Patents for C07F 5 - Compounds containing elements of the 3rd group of the periodic system (13,801)
01/2006
01/04/2006EP1611167A2 Catalyst system for the polymerization of olefins
01/03/2006US6982324 gadolinium complexes having degradable disulfide bond and characterized by prolonged blood circulation time and enhanced permeability and retention in solid tumors, but still capable of being rapidly cleared from the body after diagnostic exams
01/03/2006US6982280 cytostaticum for example; use as medicaments and plant protection agents; synthetic methods which include a Suzuki coupling or a silent coupling (stille Kupplung)
01/03/2006US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus
01/03/2006CA2383203C Ligands and asymmetric catalysts made by using the same
12/2005
12/29/2005WO2005123749A1 Organoboron compound comprising sulphur pentafluoride
12/29/2005WO2005123652A1 Rare earth metal complex light-emitting material having aromatic organic ligand
12/29/2005WO2005123144A2 System and method for an automated synthesis of gallium-68 generator-based radiopharmaceutical agents
12/29/2005WO2005123094A2 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
12/29/2005US20050288523 Chiral diphosphorus compounds and transition metal complexes thereof
12/29/2005US20050288269 Analogs of benzoquinone-containing ansamycins and methods of use thereof
12/29/2005US20050288253 Boronic acid salts
12/29/2005US20050287618 Labeling or detecting of immobilized poly(amino acids), including peptides, polypeptides and proteins, on membranes and other solid supports;
12/29/2005US20050287074 Matrix metalloproteinase inhibitors
12/29/2005CA2570477A1 Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones
12/28/2005EP1610126A1 A system for determining the electrical potential across a membrane
12/28/2005EP1609794A2 Ionic compound, resin composition containing the same and use thereof
12/28/2005EP1608665A1 Solid-phase saccharide sensing compounds
12/28/2005CN1714061A Apparatus and method for purifying an organic electroluminescent material
12/28/2005CN1712405A Ionic compound, resin composition containing the same and use thereof
12/27/2005US6979708 A synthetic hydrotalcite of the general formula:(M2+1-xM3+x(OH)2)x+(An-x/n.mH2O)x-wherein M2+ is a divalent cation, M3+ is a trivalent cation and An- is at least one organic anion with functional groups containing carboxyles
12/27/2005US6979370 Methods, complexes, and system for forming metal-containing films
12/27/2005CA2314740C Electrolyte for electrochemical device
12/22/2005WO2005120584A2 Radiolabeled arylsulfonyl compounds and uses thereof
12/22/2005WO2005097808A3 Polyhydroxy hydrogensulfated trimetallic nitride endohedral metallofullerenes
12/22/2005WO2005097807A3 Pegylation and hydroxylation of trimetallic nitride endohedral metallofullerenes
12/22/2005WO2005002007A3 Process for producing semiconductor nanocrystal cores, core-shell, core-buffer-shell, and multiple layer systems in a non-coordinating solvent utilizing in situ surfactant generation
12/22/2005US20050283016 Impurity contents; organosilicon components < 0.1 ppm, chlorine < 20 ppm, hydrocarbons < 1,000 ppm, Calcium < 0.05 ppm, Iron <0.05 ppm, Magnesium < 0.05 ppm, Sodium < 0.05 ppm, Silicon < 0.07 ppm, Zinc < 0.05 ppm, Sulfur < 0.05 ppm
12/22/2005US20050283015 distilling while blowing an inert gas through a vapor of an organopolysiloxane impurity; industrially and easily removing impurities of high vapor pressures at high efficiency; trimethylaluminum; for semiconductor use
12/22/2005US20050282780 benzoxazoles derivatives such as 2-(4-Trifluoromethoxy-phenyl)-benzooxazole-5-carboxylic acid, used for the treatment of Alzheimer's disease, spongiform encephalopathy, polyneuropathy, cardiomyopathy, non-insulin dependent diabetes and medullary carcinoma of the thyroid
12/22/2005US20050282779 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
12/22/2005US20050282778 Combining 1-monoacyldipyrromethane with a boron compound to produce a metal complex
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050281741 Using cyanine dyes; in situ target tumor cells
12/22/2005DE102004027332A1 New organometallic transition metal compound useful as catalyst constituents of catalyst systems for the polymerization of ethylene
12/21/2005EP1606012A2 Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy
12/21/2005CN1711301A Aryl-substituted polyindenofluorenes for use in organic electroluminiscent devices
12/15/2005WO2005118654A1 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins
12/15/2005WO2005118511A2 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/15/2005WO2005071096A3 Derivatives of cephalosporin and clavulanic acid for detecting beta-lacamase in a sample
12/15/2005US20050278020 Medical device
12/15/2005US20050276755 Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
12/15/2005US20050276754 Bridged aromatic substituted amine ligands with donor atoms
12/15/2005US20050276751 System and method for an automated synthesis of gallium-68 generator-based radiopharmaceutical agents
12/15/2005DE102004022628A1 FRET-Bioassay FRET bioassay
12/15/2005CA2569163A1 Factor viia inhibitor
12/14/2005EP1604994A1 Fluorescent probes
12/14/2005EP1603924A2 Alcoholates of rare earth mtals a precursors for metaloxides layers or films
12/14/2005EP1603918A1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof
12/14/2005CN1708570A Method for the production of monomers useful in the manufacture of semiconductor polymers
12/14/2005CN1231485C Stable concentrated rare earth carboxylate liquids
12/13/2005US6974884 Improved methods for synthesis of phosphinothiol reagents and novel protected reagents for use in peptide ligation
12/08/2005US20050272947 Reacting a lower trialkylaluminum with an ammonium or group 1a metal alkanolate to form a complex of ammonium or a group 1a metal (M), aluminum (Al) and four alkyl groups, MAIR4 in an aromatic hydrocarbon solvent; ready-for-use electrolyte
12/08/2005US20050272704 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/08/2005US20050272702 Coupling process for generating reactive boron-containing derivatives of N-substituted pyrrole-2-carbonitriles to produce biaryls
12/08/2005US20050271592 Optical diagnostic and therapeutic agents and compositions
12/08/2005DE102005012143A1 Verfahren zur Herstellung eines Kontaktprodukts; A process for producing a contact product; Katalysatorkomponente zur Additionspolymerisation; A catalyst component for addition polymerization; Verfahren zur Herstellung eines Katalysators zur Additionspolymerisation und Verfahren zur Herstellung eines Additionspolymers A process for producing a catalyst for addition polymerization and process for producing an addition polymer
12/08/2005DE102004022900A1 Chirale Diphosphorverbindungen und deren Übergangsmetallkomplexe Chiral diphosphorus and their transition metal complexes
12/07/2005EP1379528A4 Pyrazolopyrimidines as therapeutic agents
12/07/2005CN1705665A 7-phenylpyrazolopyridine compounds
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972326 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
12/06/2005US6972193 dimerization or oligomerization of intracellular proteins to activate genetic transcription; signal transduction and activators of transcription
12/01/2005WO2005113523A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005WO2005112913A1 Transthyretin stabilization
12/01/2005WO2005084686A3 Boronate medicaments for preventing thrombosis during surgery
12/01/2005US20050267071 Inhibitors of coronavirus protease and methods of use thereof
12/01/2005US20050266068 Cardiolipin molecules and methods of synthesis
12/01/2005DE102004023277A1 Neue Materialmischungen für die Elektrolumineszenz New material mixtures for electroluminescence
12/01/2005CA2566923A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005CA2566688A1 Transthyretin stabilization
11/2005
11/30/2005EP1600449A1 Process for producing an ester, acetal, ketal, ether or alkyl glycoside
11/30/2005EP1599609A2 Methods and compositions for detection and analysis of polynucleotide-binding protein interactions using light harvesting multichromophores
11/30/2005EP1599514A2 Catalyst system for the polymerization of olefins
11/30/2005EP1599203A1 1,3-substituted cycloalkyl derivatives containing acidic, mainly heterocyclic groups, corresponding production method and use of said derivatives as medicaments
11/30/2005EP0993463B1 Alkene borates and a process for covalently coupling organic compounds
11/30/2005CN1702065A Fluorene-based compound and organic electroluminescent display device using the same
11/30/2005CN1229357C Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-l,4,7,10-tetraazacyclododecane, prodn. and use thereof
11/29/2005US6969510 Glycine-free antiperspirant salts with Betaine for enhanced cosmetic products
11/24/2005WO2005111172A2 Novel material mixtures for use in electroluminescence
11/24/2005WO2005084685A3 Boronate medicaments suitable for short duration anticoagulation
11/24/2005WO2005080403A3 Chemical process
11/24/2005US20050261519 Forming the facial isomer by heating the solid complex at least 50 degrees C. below its melting point convert the complex to at least 99 mol % of one polymorph of the facial-isomer that fluoresces with a maximum intensity below 510 nm.
11/24/2005US20050261366 Tri(alkylcarboxylato)gallium (III) products and pharmaceutical compositions containing them
11/24/2005US20050261365 Transthyretin stabilization
11/24/2005US20050261264 Rare-earth ternary complex
11/24/2005US20050260127 Diagnostic compounds comprising a scaffold coupled to a signal entity for medical imaging diagnostic
11/23/2005EP1597254A1 Indole-derivative modulators of steroid hormone nuclear receptors
11/23/2005CN1699374A 2-acetyl benzimidazolyl glycine-condensate Schiff base rare-earth complex and process for preparing same
11/23/2005CN1228257C Organ boron waste stream treatment using hydrogen peroxide
11/17/2005WO2005108410A1 Phosphorus substituted metallocene compounds for olefin polymerization
11/17/2005WO2005108406A1 Bridged bi-aromatic catalysts, complexes, and method of using the same
11/17/2005WO2005108405A2 Lanthanide chelates and use thereof in bioanalysis
11/17/2005WO2005108372A1 Process to make metal complexes with volatile liquid metal compounds
11/17/2005WO2005073240A3 Novel hiv protease inhibitors
11/17/2005US20050256331 Manufacture of fluorinated alcohols
11/17/2005US20050256282 Process for producing contact product; catalyst component for addition polymerization; process for producing catalyst for addition polymerization; and process for producing addition polymer
11/17/2005US20050255465 Novel fluorescent label compounds
11/17/2005CA2562090A1 Bridged bi-aromatic catalysts, complexes, and methods of using the same
11/16/2005EP1596445A1 Process for doping organic semiconductors with derivatives of diiminoquinones
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 139